Virtual Medicinal Product (VMP) - Generic Maxitrol eye drops
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Generic Maxitrol eye drops | Start Date SOT | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Ocular
- Form
- Eye drops
- Ontology Form/Route
- solutiondrops.ophthalmic
- Name Basis
- Other
Codes
- ATC Code
- S01CA01
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 11040100 | Start Date 04-04-2022 | End Date |
| Previous BNF 11040100 | Start Date 15-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 3546611000001108 | SOT |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Dexamethasone | Based on Ingredient Substance | 1 mg | 1 ml | |
| Hypromellose | Based on Ingredient Substance | 5 mg | 1 ml | |
| Neomycin sulfate | Based on Base Substance | Neomycin | 3500 unit | 1 ml |
| Polymyxin B sulfate | Based on Ingredient Substance | 6000 unit | 1 ml |
Name
Hypromellose
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Name
Dexamethasone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
1.0
Name
Neomycin sulfate
Basis of strength description
Based on Base Substance
BOSS
Neomycin
Strength and UOM (Nmr)
3500.0
Strength and UOM (Dmr)
1.0
Name
Polymyxin B sulfate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
6000.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMNo Parent VTM
-
VMP(Current) Generic Maxitrol eye drops
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 5 ml |